Regencell Bioscience Holdings Limited RGC

6.17 0.00 0.00% as of 25 Sep
Market cap
$3.1B
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '25 Jun '25 Jun '24 Jun '23 Older periods
ROE
0.00% 0.00% 0.00% (336.98%)

+7 more TTM periods

ROA
0.00% 0.00% 0.00% (207.77%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% (112.86%)
Free Cash Flow per Share
0.00 0.00 0.00 0.00
Free Cash Flow
(14.67) (18.31) (15.81) (12.19)
Capital Expenditures
— (0.97) (0.81) (0.82)
Piotroski F-Score
— — — 1.00
Other line items
Cash ROIC
(410.18%) (177.78%) (92.70%) (48.28%)
Tax Rate
— — — 0.00
Research and Development Expense of Revenue
— — — 0.00%
Selling, General and Administrative Expense of Revenue
— — — 0.00%
Operating CF/Net income
0.00 0.00 0.00 0.84
Depreciation/Fixed assets
0.00 0.77 0.84 0.53
Capex/Depreciation
— (1.17) (1.05) (1.70)
Revenue per Share
— — — 0.00
Operating CF per Share
0.00 0.00 0.00 0.00
Capex per Share
— 0.00 0.00 0.00
Capex to Sales
— 0.00 0.00 0.00
Net Profit Margin
— — — 0.00%

Fold the line items

Columns are period end dates